Atlas Trials

Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum Levels (56 Characters)

Clinical trial NCT00497562 · COMPLETED

Trial details

NCT number
NCT00497562
Sponsor
Centro Medico Teknon
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
FibromyalgiaGrowth Hormone Deficiency
Start date
2004-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.